Innovation
16 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 150 times.
Investor mix
16 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 16 | 100% |
Endothelin receptor antagonist drugs for cardiovascular conditions
16 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 150 times.
16 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 16 | 100% |